SUNPHARMA1,850.00

Sun Pharmaceutical Industries Ltd.

· Pharma & Health
₹ CrorePeersCIPLADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹4.44L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt2,845.71,869.64,081.64,081.6
Net Debt-15,024.5-22,055.2-26,622.4-26,622.4
Total Debt/Equity0.040.030.050.05
Net Debt/Equity-0.22-0.30-0.32-0.32
Total Debt/EBITDA0.220.120.230.23
Net Debt/EBITDA-1.15-1.44-1.50-1.49
Interest Coverage (EBIT/Interest)43.8954.8843.6543.65
Total Debt/Total Capital %4.072.514.644.64
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 199%.